Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
1999 · British Journal of Cancer · 114 citations
https://doi.org/10.1038/sj.bjc.6690335
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
452
Citations
10
h-index
10
i10-index
Marc G. A. van Ijken is an academic researcher from Ziekenhuis Bethesda. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Sarcoma Diagnosis and Treatment & Virus-based gene therapy research. The author has an h-index of 10, co-authored 12 publications.
Click to start Chat